FOLH1 and metastatic prostate carcinoma: Bone metastases are the most frequent site of distant metastasis in prostate cancer and PSMA-PET/CT is evolving as the standard of care imaging method for metastatic prostate cancer (Zacho et al. 2018; Gandaglia et al. 2014).